Federal Register / Vol. 78, No. 49 / Wednesday, March 13, 2013 / Notices 15975 

This procedure is to be conducted 

simultaneously with, and independent 

of, the procedures described in 21 CFR 

1301.34(b), (c), (d), (e), and (f). As noted 

in a previous notice published in the 

Federal Register on September 23, 1975, 

40 FR 43745–46, all applicants for 

registration to import a basic class of 

any controlled substances in schedules 

I or II are, and will continue to be, 

required to demonstrate to the Deputy 

Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration, that the requirements 

for such registration pursuant to 21 

U.S.C. 958(a); 21 U.S.C. 823(a); and 21 

CFR 1301.34(b), (c), (d), (e), and (f) are 

satisfied. 

Dated: March 7, 2013. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. 2013–05793 Filed 3–12–13; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances, 

Notice of Registration: Hospira Inc. 

By Notice dated December 14, 2012, 

and published in the Federal Register 

on December 21, 2012, 77 FR 75670, 

Hospira Inc., 1776 North Centennial 

Drive, McPherson, Kansas 67460–1247, 

made application by renewal to the 

Drug Enforcement Administration 

(DEA) to be registered as an importer of 

Remifentanil (9739), a basic class of 

controlled substance listed in schedule 

II. 

The company plans to import 

Remifentanil for use in dosage form 

manufacturing. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 952(a), 

and determined that the registration of 

Hospira Inc. to import the basic class of 

controlled substance is consistent with 

the public interest, and with United 

States obligations under international 

treaties, conventions, or protocols in 

effect on May 1, 1971, at this time. DEA 

has investigated Hospira Inc. to ensure 

that the company’s registration is 

consistent with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems, verification of the 

company’s compliance with state and 

local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 952(a) 

and 958(a), and in accordance with 21 

CFR 1301.34, the above named company 

is granted registration as an importer of 

the basic class of controlled substance 

listed. 

Dated: March 7, 2013. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. 2013–05794 Filed 3–12–13; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances, Notice of Registration; 

Johnson Matthey, Inc., 

Pharmaceuticals Materials 

By Notice dated November 1, 2012, 

and published in the Federal Register 

on November 9, 2012, 77 FR 67397, 

Johnson Matthey, Inc., Pharmaceuticals 

Materials, 900 River Road, 

Conshohocken, Pennsylvania 19428, 

made application by renewal to the 

Drug Enforcement Administration 

(DEA) to be registered as a bulk 

manufacturer of the following basic 

classes of controlled substances: 

Drug Schedule 

Gamma Hydroxybutyric Acid 

(2010).

I 

Amphetamine (1100) .................... II 

Methylphenidate (1724) ................ II 

Codeine (9050) ............................. II 

Oxycodone (9143) ........................ II 

Diphenoxylate (9170) ................... II 

Hydrocodone (9193) ..................... II 

Meperidine (9230) ........................ II 

Methadone (9250) ........................ II 

Methadone intermediate (9254) ... II 

Morphine (9300) ........................... II 

Thebaine (9333) ........................... II 

The company plans to manufacture 

the listed controlled substances in bulk 

for distribution and sale to its 

customers. 

The Thebaine (9333) will also be used 

to manufacture other controlled 

substances for sale in bulk to its 

customers. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 

determined that the registration of 

Johnson Matthey Inc., Pharmaceuticals 

Materials to manufacture the listed basic 

classes of controlled substances is 

consistent with the public interest at 

this time. DEA has investigated Johnson 

Matthey Inc., Pharmaceuticals Materials 

to ensure that the company’s 

registration is consistent with the public 

interest. The investigation has included 

inspection and testing of the company’s 

physical security systems, verification 

of the company’s compliance with state 

and local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 

823(a), and in accordance with 21 CFR 

1301.33, the above named company is 

granted registration as a bulk 

manufacturer of the basic classes of 

controlled substances listed. 

Dated: February 27, 2013. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. 2013–05799 Filed 3–12–13; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF LABOR 

Office of the Secretary 

Agency Information Collection 

Activities; Submission for OMB 

Review; Comment Request; Job Clubs 

Study 

ACTION: Notice; correction. 

SUMMARY: The Department of Labor 

published a document in the Federal 

Register of February 26, 2013, 

concerning request for comments on site 

visits to job clubs. The document 

contained incorrect dates. 

FOR FURTHER INFORMATION CONTACT: 

Contact Ben Seigel by telephone at 202– 

693–6032 (this is not a toll-free number) 

or by email at CFBNP@dol.gov. 

Correction 

In the Federal Register of February 

26, 2013, in FR Doc. 2013–04391, on 

page 13086, in the second column, 

correct the DATES caption to read: 

DATES: Written comments must be 

submitted to the office listed in the 

addressee section on or before April 27, 

2013. 

Signed at Washington, DC, this 5th day of 

March, 2013. 

Irasema Garza, 

Acting Assistant Secretary for Policy, U.S. 

Department of Labor . 

[FR Doc. 2013–05775 Filed 3–12–13; 8:45 am] 

BILLING CODE P 

mstockstill on DSK4VPTVN1PROD with NOTICES